4//SEC Filing
Durata Therapeutics, Inc. 4
Accession 0001012975-14-000749
CIK 0001544116operating
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:10 PM ET
Size
15.9 KB
Accession
0001012975-14-000749
Insider Transaction Report
Form 4
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−3,028,439→ 0 total(indirect: See Footnote)
CHAMBON PHILIPPE
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−3,028,439→ 0 total(indirect: See Footnote)
Lathi Vijay K
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−3,028,439→ 0 total(indirect: See Footnote)
Ratcliffe Liam
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−3,028,439→ 0 total(indirect: See Footnote)
New Leaf Venture Associates II, L.P.
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−3,028,439→ 0 total(indirect: See Footnote)
Delagardelle Jeani
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−3,028,439→ 0 total(indirect: See Footnote)
New Leaf Ventures II, L.P.
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−3,028,439→ 0 total(indirect: See Footnote)
Footnotes (2)
- [F1]Disposed of pursuant to a tender offer by a subsidiary of Actavis plc ("Actavis") for all of the outstanding shares of the Issuer's common stock, having a value of $23.00 per share in cash and one contingent value right ("CVR") per share, entitling the holder to receive additional cash payments of up to $5.00 per CVR if certain regulatory or commercial milestones related to products of the Issuer are achieved. As of November 17, 2014, the Issuer was merged into a subsidiary of Actavis and became an indirect wholly-owned subsidiary of Actavis.
- [F2]Represents shares directly beneficially owned by New Leaf Ventures II, L.P. ("NLV II"). New Leaf Venture Associates II, L.P. ("NLV Associates") is the general partner of NLV II and New Leaf Venture Management II, L.L.C. ("NLV Management") is the general partner of NLV Associates. Philippe O. Chambon, Jeani Delagardelle, Ronald Hunt, Vijay Lathi, and Liam Ratcliffe are the individual managers of NLV Management (the "Individual Managers"). NLV Associates and NLV Management disclaim beneficial ownership of such shares, except to the extent of their pecuniary interest therein. As one of five individual managers, each of the Individual Managers disclaims beneficial ownership over the shares reported herein, and in all events disclaims pecuniary interest except to the extent of his economic interest.
Documents
Issuer
Durata Therapeutics, Inc.
CIK 0001544116
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001544116
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:10 PM ET
- Size
- 15.9 KB